Plantar Fasciitis Clinical Trials
Here are the 6 most popular medical studies for plantar fasciitis
Platelet Rich Plasma Therapy
Autologous Conditioned Plasma (ACP) for Plantar Fasciitis
Plantar fasciitis presents clinically as pain in the inner heal, which is the result of degeneration of the plantar fascia, an arch supporting ligament of the foot. It manifests predominantly in those subjected to sustained weight bearing or repetitive pounding activities. Plantar fasciitis is the most common cause of inferior foot pain. Although most cases resolving within 6 months, traditional treatment regiments such as orthotics and physiotherapy are occasionally unsuccessful in treating this limitation leading to chronic symptoms (Neufeld & Cerrato, 2008; Rompe, 2009; Roxas, 2005). Platelets are central players in clotting, inflammation and the wound healing response. Research has shown the potential of platelet rich plasma to accelerate wound healing in a variety of conditions including maxillo-fascial and plastic surgery, chronic wound healing and orthopaedics. Autologous Conditioned Plasma (ACP) is a novel treatment that may accelerate the healing of injured tissue. Treatment with ACP involves taking a blood sample from the patient, isolating the platelets and injecting them back into that patient at the injury site
Procedure
Waterproof Padding vs Non-waterproof Padding for Short Leg Walking Casts
This trial will compare the use of waterproof padding in short leg walking casts to the standard non-waterproof casting in children to see if there is an increase in cast-related complications.
Popular filter options for plantar fasciitis trials
Plantar Fibroma Clinical Trials
View 6 Plantar Fibroma medical studies.
Regenerative Injection Therapy
Regenerative injection therapy for Plantar Fibroma
The purpose of this study is to demonstrate that prolotherapy in conjunction with a physiotherapy program looking at reinforcing calf muscle and muscle of the plantar fascia, relieves pain and improves function of people suffering of plantar fasciitis, an inflammation of the plantar fascia, after basic treatment failure.
Plantar Fasciitis Clinical Trials With No Placebo
View 18 plantar fasciitis medical studies that do not have a placebo group.
Behavioural Intervention
Foot Rehab + Minimalist Shoes for Plantar Fasciitis
This trial will compare the effects of doing foot rehab exercises and wearing minimalist shoes to just doing foot rehab exercises for reducing pain, improving function, increasing muscle strength, and improving balance and gait.
Procedure
Corticosteroid Injection +1 More for Plantar Fasciitis
The objective of this clinical trial is to evaluate both the safety and efficacy of the ReNuâ„¢ injection on pain and inflammation in subjects diagnosed with plantar fasciitis as compared to a Corticosteroid Injection which is considered standard of care.
Frequently Asked Questions
Introduction to plantar fasciitis
What are the top hospitals conducting plantar fasciitis research?
Plantar fasciitis, a common and often debilitating condition that affects the feet, is being actively addressed by top hospitals across the United States. In Winston-Salem, Wake Forest University Health Sciences takes the lead with their ongoing clinical trial dedicated to plantar fasciitis. This groundbreaking study marks their first recorded trial in 2023, showcasing their commitment to finding effective treatment options for this condition. Meanwhile, Madigan Army Medical Center in Tacoma is also making strides with an active plantar fasciitis trial and a history of one completed study since initiating their research efforts in 2022.
In Salt Lake City, the VA Salt Lake City Health Care System joins these pioneering institutions with an ongoing clinical trial targeting plantar fasciitis. Their dedication to understanding this condition began in 2022 and underscores their commitment to improving patient outcomes.
The UF Health Orthopaedics and Sports Medicine Institute located in Gainesville has similarly undertaken an active plantar fasciitis trial alongside its counterparts nationwide. With its inaugural investigation launched in 2022, they are helping pave the way toward potential breakthroughs for those suffering from this painful foot ailment.
Last but not least is New york's Hospital for Special Surgery which stands out within this group of esteemed hospitals. They have already made significant contributions through their comprehensive approach towards addressing plantar fasciitis. Having initiated a clinical trial as early as 2020 specifically tailored towards this condition, they continue to explore innovative treatments that may alleviate pain and improve quality of life for patients.
These progressive initiatives reflect how medical professionals are working tirelessly across multiple locations to tackle plantar fasciitis head-on while expanding our understanding of its causes and developing novel interventions that can provide hope for individuals grappling with this challenging foot disorder.
Which are the best cities for plantar fasciitis clinical trials?
When it comes to plantar fasciitis clinical trials, several cities show promising research opportunities. Tacoma, Washington leads the way with 2 active trials examining treatments like The Usual Care + PBM Group and Custom PFO orthosis. Winston-Salem, North carolina follows closely behind with 1 ongoing trial focused on corticosteroid injection/local anesthetic (CSI/LA). Salt Lake City, Utah and Gainesville, Florida also contribute to the advancement of knowledge in this field with 1 active trial each exploring Botulinum Toxin A and Control Cohort interventions respectively. Additionally, New york, New York joins the ranks with its own ongoing study investigating control methods for this condition. These cities offer individuals suffering from plantar fasciitis access to innovative clinical trials that may lead to improved treatment options and better outcomes.
Which are the top treatments for plantar fasciitis being explored in clinical trials?
Plantar fasciitis, a common condition causing heel pain, is the focus of ongoing clinical trials exploring potential treatments. Two notable contenders in these studies are Botulinum Toxin A and Control Cohort. Both have one active trial dedicated to plantar fasciitis and were first listed in 2022. As researchers delve deeper into their efficacy, they hold promise for providing relief to individuals suffering from this painful foot ailment.
What are the most recent clinical trials for plantar fasciitis?
Exciting progress is being made in the field of plantar fasciitis research, as recent clinical trials offer promising insights into its treatment. One notable trial explores the effectiveness of corticosteroid injection/local anesthetic (CSI/LA) for managing this condition. Another study focuses on Botulinum Toxin A and its potential therapeutic benefits, with phases 2 and 3 already completed. Additionally, a phase 2 trial examines AbobotulinumtoxinA 300 UNT as a possible treatment option. While these trials showcase advancements in plantar fasciitis management, it's important to note that regenerative injection therapy has been available since May 2011 but continues to be explored further through a phase 4 trial. These developments provide hope for individuals suffering from plantar fasciitis and pave the way for improved care strategies moving forward
What plantar fasciitis clinical trials were recently completed?
Recently completed clinical trials have shed light on the treatment of plantar fasciitis, a common and painful foot condition. These studies have provided valuable insights into potential therapeutic approaches for this ailment. Efforts led by prominent researchers and institutions have yielded noteworthy results in our quest to alleviate plantar fasciitis symptoms. Stay tuned for more comprehensive information regarding these groundbreaking trials as we strive to better understand and effectively address this debilitating condition affecting countless individuals worldwide.